Alkeon Capital Management LLC Denali Therapeutics Inc. Transaction History

Alkeon Capital Management LLC

  • $58.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$36.89 - $93.56 $5.9 Million - $15 Million
-160,000 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$23.13 - $38.84 $1.39 Million - $2.33 Million
60,000 Added 60.0%
160,000 $5.73 Million
Q1 2020

May 15, 2020
BUY
$14.2 - $27.98 $1.42 Million - $2.8 Million
100,000 New
100,000 $1.75 Million

Others Institutions Holding DNLI

# of Institutions
227
Shares Held
119M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $2.88B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Alkeon Capital Management LLC Portfolio

Follow Alkeon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alkeon Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email